Jenna Skrajewski
Acute Care · Plainsboro, NJNPI 1184480964
Payments from drug & device makers
Across 40 payments — averaging $28.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$342
- Medtronic$113
- Astellas Pharma US Inc$104
- 180 Medical, Inc.$59
- Novartis$53
- Sumitomo Pharma America, Inc.$53
- plus $410 from 13 others
What the payments were for
- Food & beverage$1,06694%
- Education$686%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $342 |
| Medtronic | 6 | $113 |
| Astellas Pharma US Inc | 3 | $104 |
| 180 Medical, Inc. | 2 | $59 |
| Novartis | 3 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Photocure Inc | 2 | $51 |
| Novo Nordisk | 2 | $48 |
| Johnson & Johnson | 2 | $44 |
| Procept Biorobotics Corporation | 1 | $41 |
| Janssen Scientific Affairs, LLC | 1 | $35 |
| AbbVie | 2 | $31 |
| Integra Lifesciences Corporation | 1 | $31 |
| ABC Home Medical Supply, Inc. | 1 | $29 |
| Laborie Medical Technologies Corp. | 1 | $25 |
| Bioprotect Medical, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $20 |
| Merck | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LithoVue$237
How this compares
$1,134 in reported general payments places this provider in the 75th percentile of 656 acute care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other acute care in Plainsboro
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Ellen McCueNeptune$26K
- Suzanne ShuggLivingston$25K
- Maria Tedi CoronelHackensack$19K
- Hanane ChaibainouWestampton$16K
- Jennifer McCarthyNewark$16K
- Jennifer HarrarCamden$16K
- Vincent FroncekFlemington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.